Quaranta, V.N.; Dragonieri, S.; Crimi, N.; Crimi, C.; Santus, P.; Menzella, F.; Pelaia, C.; Scioscia, G.; Caruso, C.; Bargagli, E.;
et al. Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study. J. Clin. Med. 2022, 11, 4702.
https://doi.org/10.3390/jcm11164702
AMA Style
Quaranta VN, Dragonieri S, Crimi N, Crimi C, Santus P, Menzella F, Pelaia C, Scioscia G, Caruso C, Bargagli E,
et al. Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study. Journal of Clinical Medicine. 2022; 11(16):4702.
https://doi.org/10.3390/jcm11164702
Chicago/Turabian Style
Quaranta, Vitaliano Nicola, Silvano Dragonieri, Nunzio Crimi, Claudia Crimi, Pierachille Santus, Francesco Menzella, Corrado Pelaia, Giulia Scioscia, Cristiano Caruso, Elena Bargagli,
and et al. 2022. "Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study" Journal of Clinical Medicine 11, no. 16: 4702.
https://doi.org/10.3390/jcm11164702
APA Style
Quaranta, V. N., Dragonieri, S., Crimi, N., Crimi, C., Santus, P., Menzella, F., Pelaia, C., Scioscia, G., Caruso, C., Bargagli, E., Kostikas, K., Kyriakopoulos, C., Scichilone, N., & Carpagnano, G. E.
(2022). Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study. Journal of Clinical Medicine, 11(16), 4702.
https://doi.org/10.3390/jcm11164702
